Why Emergent BioSolutions (EBS) Paid $26 Million for Anti-Chem Lotion From Bracco Diagnostics Inc.
4/26/2013 7:47:49 AM
More...
|
Bracco Diagnostics Inc. Recalls Isovue PFS Injector Syringes
11/28/2012 6:38:12 AM
More...
|
FDA Approves Use of Bracco Diagnostics Inc.'s MultiHance Injection in MRA
7/30/2012 7:48:17 AM
More...
|
Bracco Diagnostics Inc. Receives U.S. FDA Approval for Expanded Labeling of MultiHance® (gadobenate dimeglumine) Injection in Magnetic Resonance Angiography
7/27/2012 10:02:47 AM
More...
|
MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco Diagnostics Inc.’s MultiHance® (gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist™ (gadobutrol injection)
3/7/2012 10:00:18 AM
More...
|
Bracco Diagnostics Inc. Resumes CardioGen-82 Shipments With New FDA-issued Box Warning Attached
2/17/2012 9:10:26 AM
More...
|
Radiation Overdoses Linked to Bracco Diagnostics Inc.'s Recalled CardioGen-82 PET Scan Device
9/27/2011 8:26:30 AM
More...
|
Positron Corporation (POSC) Release: Bracco Diagnostics Inc. Reports Cardiac PET Growth
6/18/2010 8:26:52 AM
More...
|
Court Rules that GE Healthcare Engaged in False Advertising Campaign Against Bracco Diagnostics Inc.
3/30/2009 9:24:17 AM
More...
|
Bracco Diagnostics Inc. and Lantheus Medical Imaging Enter into Agreement to Co-Promote Bracco’s CardioGen-82® (Rubidium Rb 82 Generator)
9/23/2008 3:24:32 PM
More...
|
|